Despite declines in total cardiovascular mortality rates in the United States, heart failure (HF)
mortality rates as well as hospitalizations and readmissions have increased in the past …

Heart failure is the most common cardiovascular complication during pregnancy and the
postpartum period. It is associated with increased risk of maternal morbidity and mortality as …

Background: Clinical utility of cardiac biomarker testing during pregnancy in women with
preexisting cardiac disease is not well known. We studied the levels and temporal trends of …

Background Chronic lung diseases are characterized by impaired lung function. Given that
many diseases have shared clinical symptoms and pathogenesis, identifying shared …

Despite the evidence demonstrating the clinical utility of cardiac specific biomarkers in
improving cardiovascular risk evaluation in several clinical conditions, even the most recent …

Background To date, the shared genes and molecular pathways between atherosclerosis
and IBD have not been investigated based on a systems biology approach. Identifying …

Pregnant persons with congenital heart disease should be cared for by a multidisciplinary
team that understands the unique hemodynamic changes that occur and how these …

Cardiovascular disease includes many diseases such as heart failure, cardiomyopathy,
valvular disease, pericardial disease, peripheral vascular disease, rheumatic heart disease …

Résumé Entre 2016 et 2018, les maladies cardiovasculaires sont responsables de 41
décès, ce qui en font la première cause de mort maternelle dans les 42 j post-partum en …

In an effort to optimize maternal outcomes, it is critical to recognize the risk associated with
various cardiomyopathies in pregnancy and understand the tools for risk stratification and …